# Endobiliary RFA for Unresectable Malignant Biliary Strictures

> **NCT01844245** · NA · COMPLETED · sponsor: **Bing Hu** · enrollment: 174 (actual)

## Conditions studied

- Cholangiocarcinoma
- Ampullary Carcinoma

## Interventions

- **PROCEDURE:** Radiofrequency ablation (RFA)

## Key facts

- **NCT ID:** NCT01844245
- **Lead sponsor:** Bing Hu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2017-12
- **Final completion:** 2019-07
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01844245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01844245, "Endobiliary RFA for Unresectable Malignant Biliary Strictures". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01844245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*